Company intelligence / Profile preview

Vivisol

Ownership: Private
Employees: ~824
Development stage: Other

Overview

Vivisol delivers commercialized home healthcare solutions across Europe with a focus on chronic disease management—especially in respiratory medicine. The company serves over 750,000 patients globally through oxygen therapy, mechanical ventilation support, sleep apnea treatment, artificial nutrition/infusion therapies, telemedicine solutions and at-home medical assistance. It does not conduct clinical trials for new therapeutics but implements evidence-based protocols and technologies to improve patient outcomes at home.

Therapeutic areas: GastroenterologyPulmonologyOther
Modalities: DeviceNon-pharmacological therapyInfusion therapyTelemedicine platform/technologyMedical device management
Industry: Non-Academic Healthcare

Partnerships

Collaborations with national health systems across EuropeAeonvis/Salesforce

Beyond the preview

Go deeper on Vivisol.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vivisol.

Explore the full profile